Search by Drug Name or NDC

    NDC 00409-1159-10 BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL Details

    BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL

    BUPIVACAINE HYDROCHLORIDE is a EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is BUPIVACAINE HYDROCHLORIDE.

    Product Information

    NDC 00409-1159
    Product ID 0409-1159_a33878a1-9d68-4a46-9913-c7be85f1d1ff
    Associated GPIs 69100010102007
    GCN Sequence Number 052193
    GCN Sequence Number Description bupivacaine HCl/PF VIAL 2.5 MG/ML INJECTION
    HIC3 H0A
    HIC3 Description LOCAL ANESTHETICS
    GCN 19757
    HICL Sequence Number 025243
    HICL Sequence Number Description BUPIVACAINE HCL/PF
    Brand/Generic Generic
    Proprietary Name BUPIVACAINE HYDROCHLORIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name bupivacaine hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/mL
    Substance Name BUPIVACAINE HYDROCHLORIDE
    Labeler Name Hospira, Inc.
    Pharmaceutical Class Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA070583
    Listing Certified Through 2024-12-31

    Package

    NDC 00409-1159-10 (00409115910)

    NDC Package Code 0409-1159-10
    Billing NDC 00409115910
    Package 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-1159-10) / 30 mL in 1 VIAL, SINGLE-DOSE (0409-1159-09)
    Marketing Start Date 2015-08-11
    NDC Exclude Flag N
    Pricing Information N/A